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Regulation of Skin Collagen Metabolism In Vitro
Using a Pulsed 660 nm LED Light Source: Clinical
Correlation with a Single-Blinded Study
Daniel Barolet1,2, Charles J. Roberge3, Franc¸ois A. Auger3,4, Annie Boucher1 and Lucie Germain3,4
It has been reported that skin aging is associated with a downregulation in collagen synthesis and an elevation
in matrix metalloproteinase (MMP) expression. This study investigated the potential of light-emitting diode
(LED) treatments with a 660 nm sequentially pulsed illumination formula in the photobiomodulation of these
molecules. Histological and biochemical changes were first evaluated in a tissue-engineered Human
Reconstructed Skin (HRS) model after 11 sham or LED light treatments. LED effects were then assessed in
aged/photoaged individuals in a split-face single-blinded study. Results yielded a mean percent difference
between LED-treated and non-LED-treated HRS of 31% in levels of type-1 procollagen and of 18% in MMP-1.
No histological changes were observed. Furthermore, profilometry quantification revealed that more than 90%
of individuals showed a reduction in rhytid depth and surface roughness, and, via a blinded clinical assessment,
that 87% experienced a reduction in the Fitzpatrick wrinkling severity score after 12 LED treatments. No adverse
events or downtime were reported. Our study showed that LED therapy reversed collagen downregulation and
MMP-1 upregulation. This could explain the improvements in skin appearance observed in LED-treated
individuals. These findings suggest that LED at 660 nm is a safe and effective collagen-enhancement strategy.
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INTRODUCTION
Skin aging, intrinsic and extrinsic, is associated with morpho-
logical changes, including rhytids, furrows, and telangiecta-
sia (Kang et al., 2001; Fisher et al., 2002). It has been reported
that collagen synthesis is reduced and interstitial matrix
metalloproteinases (MMP-1), the collagenase involved in
normal turnover of skin collagen, are upregulated in aged
skin (Fligiel et al., 2003; Fisher et al., 2008; Varani et al.,
2004). Hence, a possible strategy for treating and preventing
clinical manifestations of skin aging is the restoration of
collagen deficiency by the induction of new collagen
synthesis and reduction of MMP-1.
It has been shown that light-emitting diode (LED) therapy,
a nonthermal noninvasive treatment, can trigger natural
intracellular photobiochemical reactions (Karu and Kolyakov,
2005; Karu et al., 2005a, b; Hamblin and Demidova, 2006;
Barolet, 2008). A number of clinical studies provide evidence
of the effectiveness of LED therapy in photorejuvenation
using a variety of LED light sources (Weiss et al., 2004; Bhat
et al., 2005; Russell et al., 2005; Weiss et al., 2005; Goldberg
et al., 2006; Baez and Reilly, 2007; Lee et al., 2007). An
improvement in skin appearance in aged/photoaged indivi-
duals has been documented after full-face or split-face serial
treatments with yellow (590 nm), red (630, 633 nm), or red in
combination with infrared (830 nm) light based on profilo-
metry quantification, clinical assessment of digital photo-
graphs, and patient reported outcomes. A correlation of
clinical effects with further analysis for basic mechanisms
was examined in two of these studies. In Weiss et al. (2005),
after a regimen of eight treatments delivered over 4 weeks
with LED 590nm, staining with anti-collagen I antibodies
showed a 28% (range of 10–70%) average increase in density,
whereas staining with anti-MMP-1 showed an average
reduction of 4% (range of 2 to 40%). In the Lee et al.
study, participants were randomly divided into four groups
treated with either 830 nm alone, 633 nm alone, a combina-
tion of 830 and 633 nm, or a sham treatment light, two times
a week for 4 weeks. In the treatment groups, a significant
increase in the amount of collagen was observed by
histological evaluation with standard preparation with
hematoxylin and eosin stain. This finding was confirmed by
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the Masson–trichrome stain for collagen. In the immunohisto-
chemical staining results, no significant changes in MMP-1 or
MMP-2 were observed between the baseline and 2 weeks
posttreatment specimens in all groups. Other models have also
been used to investigate LED-based effects. Collagen increase
after LED treatment has been documented in fibroblast cultures
(McDaniel et al., 2002; Huang et al., 2007), in third-degree
burn wound-healing models (Meireles et al., 2008a, b), and in
human blister fluids (Barolet et al., 2005). However, con-
current MMP determinations after LED treatment were not
assessed in these experiments.
In this study, we opted for an innovative approach
involving a stable in vitro model replicating a real-life LED
clinical application, and then sought to explore clinical
correlates of these effects in humans. The 660 nm LED light
source delivered in a sequential pulsing mode was used as it
is a deep penetrating well-absorbed wavelength that falls into
the absorption peaks of cytochrome c oxidase, the chromo-
phore thought to be responsible for LED effects (Karu and
Kolyakov, 2005; Karu et al., 2005a, b).
A 3-D model of tissue-engineered Human Reconstructed
Skin (HRS) (Michel et al., 1999) was used to initially
investigate the potential of 660nm LED in modulating collagen
and MMP-1. The HRS model offers a variety of advantages
over other in vitro and preclinical models. HRS samples are
produced exclusively from human fibroblasts and keratino-
cytes and do not contain any synthetic material. This model
emulates skin as a complex tissue composed of two different
compartments, the continuously renewing epidermis made up
mostly of keratinocytes and the underlying dermal matrix with
fibroblasts as its major cellular components. These compart-
ments are tightly interconnected allowing for paracrine mutual
interactions, which are essential for epidermal growth,
differentiation, and tissue homeostasis. This HRS model
represents a unique opportunity to test biological changes
after LED treatment over an extended time frame on age- and
gender-defined skin, much like a clinical setting. Eleven
consecutive LED treatments carried out over 4 weeks were
conducted on HRS and compared with the untreated control
specimens for type I procollagen and MMP-1 production. The
clinical study was then conducted to corroborate the in vitro
experiment. A group of chronologically aged/photoaged
individuals received 12 LED treatments or a sham light control
over a 1-month period (split-face study). Clinical improve-
ments were assessed with an in vivo 3-D microtopography
quantitative measurement (PRIMOS readings) and a qualitative
clinical assessment of digital photographs by blinded medical
observers. Our results supported the hypothesis that LED
treatments could upregulate collagen and downregulate
MMP-1 in vitro, and thus lead to improvements in skin
appearance observed in the LED-treated side in humans.
RESULTS
LED-induced modulations in type I procollagen and MMP-1
production of human reconstructed skin
Type I procollagen and MMP-1 production was assessed in the
supernatants of HRS from individuals with aged/photoaged skin
in response to each of the 11 LED treatments (T1–T11)
conducted over a 1-month period. An increase in type I
procollagen production with a concomitant decrease in
MMP-1 levels was observed in the LED-treated samples
when compared with that in untreated samples. The latter
effects were found to be cyclic, with alternating high and low
levels observed in response to consecutive LED treatments
The mean percent difference between LED-treated and
untreated HRS specimens across repeated treatments was
31% (range of 5–81%) for type I procollagen levels and 18%
(range of 3 to 27%) for MMP-1 levels (Figure 1). Cohen’s d
effect size was in the medium-to-large range at the various
time points for both type-1 procollagen and MMP-1
measurements, with the exception of T9 (dp0.2) (see Table
below Figure 1).
Histological assessments on HRS
Morphological changes after the last LED treatment were
assessed using Masson’s trichrome and immunofluorescent
staining. Masson staining of reconstructed skin showed no
histological difference in the extracellular matrix (same
dermal thickness) in LED-treated compared with untreated
control samples (data not shown). Typical results from
an LED-treated HRS are depicted in Figure 2a (HRS38).
Immunofluorescent staining of HRS yielded no difference in
the amounts of type I procollagen (same band thickness)
between the LED-treated and untreated specimens (data
not shown). A representative fluorescent immunostaining
pattern after LED treatment for type I procollagen is displayed
in Figure 2b. Overall, after LED treatments, the dermal layer
exhibited a dense well-organized collagenous connective
tissue material, overlaid with a well-stratified epidermis,
presenting an intact stratum basale.
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Figure 1. Increases in type I procollagen and concurrent reduction in
MMP-1 levels in HRS after LED treatment. A cyclic pattern of alternating
highs and lows was observed in response to the 11 consecutive treatments
(T1–T11) for type 1 procollagen and MMP levels. Values are percent
difference±SEM (n¼9) between treated and untreated control HRS samples
in mean levels of type I procollagen and MMP-1 assessed in the supernatants
after each treatment. Table shows Cohen’s d for type 1 procollagen and
MMP-1 for each time point.
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Profilometry quantification of improvements in skin appearance
To assess the potential of 660 nm LED light in improving the
appearance of aged/photoaged skin, participants were treated
weekly three times for four consecutive weeks (12 treatments)
with an LED and sham light contralaterally in a split-face
design. Results from a microtopographic profilometry analy-
sis (PRIMOS reading) of rhytid depth and severity (Rz) and
reduction in skin roughness (Ra) are presented in Table 1.
Analysis of the results showed that the percent improvement
after treatment in Rz values was statistically different between
the LED-treated and control non-treated sides (Po0.0001).
LED treatment produced an Rz reduction in 94% of
participants, with the highest reduction in rhytids of 51%
noted on a female participant aged 46 years (S33). For
the non-treated side, Rz reductions were observed in 51%
of participants. The results from the LED-treated side
also revealed a statistically significant reduction in surface
roughness in comparison with the untreated control side
(Po0.0001), as measured by Ra. Overall, an improvement in
skin appearance after LED treatment was observed in 97%
of participants, with the highest benefit of 56% observed
on a woman aged 57 years (S29). For the untreated side,
improvements were observed in 46% of participants. The
participant’s age was not found to influence the effect of LED
treatment on Rz or Ra values. Figure 3 shows PRIMOS phase
shift black and white and color-coded microtopography
photographs before and after LED therapy of the periorbital
area for participant S2.
Skin textural enhancement in aged/photoaged participants
Clinical assessment of digital photographs taken before
treatment and after the last treatment were analyzed by three
blinded medical observers. According to the observers, an
improvement in at least one subtype of the Fitzpatrick
Classification System (FCS), used to evaluate the degree of
wrinkling (rhytids), was obtained in 85–90% (mean of 87%)
of participants after LED treatments. For the untreated side,
an improvement was observed in 25–63% of participants
(mean of 45%). Observer assessments revealed that the
degree of improvements in wrinkling after treatment was mild
to moderate. The analysis conducted on severity scores
showed that there was a significant difference between the
LED-treated and untreated sides for Observers 1 (Po0.0001)
and 3 (P¼ 0.001), but not according to Observer 2 (Table 2).
Results were not found to be influenced by the participant’s
Figure 2. Histological assessments of HRS. (a) Masson stain after LED
treatment on reconstructed skin (HRS38), underlining the presence of
dermal collagen (colored in blue) in the dermal portion. Keratinocytes found
in the epidermis and dermal fibroblasts are colored in red. (b) Fluorescent
immunostaining of HRS42 type I collagen located in the dermal portion
(red band pattern) after LED treatment. Nuclei are colored in blue for both
keratinocytes (round nuclei) and dermal fibroblasts (elongated nuclei).
No morphological changes were observed on HRS after LED treatments.
Scale bar indicates 50 mm.
Table 1. Microtopographic profilometry analysis
Percent improvement
post-treatment
Percentage of subjects
with improvement
LED-
treated Untreated P-value
LED-treated
(%)
Untreated
(%)
Ra 18.57±2.41 3.73±1.17 o0.0001 97 46
Rz 20.83±2.26 7.43±1.64 o0.0001 94 51
Values are mean±SEM.
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Figure 3. Reduction in rhytids and skin roughness with LED therapy.
Photograph depicts color-coded topography images before treatment (a) and
after LED treatment (c). Each color determines a specific depth with
darker areas indicating a deeper wrinkle surface. Black and white
photographs show skin texture and pore size for the pre-LED (b) and
post-LED treatment areas (d). All photographs are for S2 aged 38 years.
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age. The internal consistency between the observers’ findings
was deemed to be acceptable (Cronbach’s a¼0.615).
Clinical results for participant S2 are displayed in Figure 4.
Skin temperature steadiness during LED treatment
It has been reported that a mild increase in temperature (43 vs
371C) can induce a decrease in type I procollagen secretion
(Halper et al., 2005). Papillary dermis temperature was thus
monitored in our clinical study throughout LED exposure to
ensure that skin temperature was kept normal in order not to
hinder photobiochemical reactions associated with collagen
metabolism. Monitoring attested that physiological tempera-
ture was maintained at the treatment area during the entire
procedure. Temperature variations registered by thermo-
couple probes during LED treatment were stable or never
more than 0.51C (dermo-epidermal junction temperature of
33±0.51C).
LED therapy safety profile in humans
Adverse reactions were monitored throughout the study. LED
therapy was found to be well tolerated by all patients, with no
adverse effects or downtime reported during or after LED
treatment.
DISCUSSION
This study investigated the potential of 660 nm sequentially
pulsed LED treatments in the photoinduction of collagen
synthesis and MMP-1 modulation in humans. LED-induced
biochemical and histological changes in a 3-D HRS in vitro
model were first examined. A clinical study was then carried
out to assess in vivo the clinical correlates of this light
treatment on skin texture and appearance of individuals
with aged/photoaged skin, in whom collagen synthesis and
MMP-1 are known to be downregulated and upregulated,
respectively (Varani et al., 2000). Results from this study
provide evidence for the photobiomodulatory effects of
660 nm sequentially pulsed LED treatment.
We have previously developed a tissue-engineering
approach for the production of a biological HRS from
cultured human cells (Laplante et al., 2001). In this study,
we took advantage of this model for our in vitro study. The
use of this tissue-engineering method allowed the creation
of three differently aged HRS, which offered the unique
opportunity to test biological changes, such as type-1
collagen and MMP-1 production, after LED treatment on
age-defined skin. The stability of these constructs in culture
over time also permitted numerous consecutive LED treat-
ments to be applied. Results obtained from the three HRS
constructs tested demonstrated that 660 nm LED exposures
did not trigger histological changes; however, LED treatment
significantly amplified collagen production with a conco-
mitant decrease in collagenase (MMP-1) production. The
noticeable differences between our results and those of other
studies were the depth and range in collagen production
increase and MMP-1 reduction in an in vitro milieu capable
of dermal–epidermal communication comparable with that
in in vivo skin (Weiss et al., 2005; Lee et al., 2007). Interes-
tingly, LED treatments can induce similar changes in collagen
synthesis and MMP activity as those reported with retinoic
acid (Fisher and Voorhees 1998; Fisher et al., 1998), although
the mechanisms at play may be different.
The pattern of procollagen and MMP-1 production was
found to be cyclic. The observed cyclical pattern could result
from the capacity of HRS to express specific endogenous cell
signaling pathways, periodically turning the factory ‘‘on’’ and
‘‘off’’. This was seen in both treated and untreated specimens,
possibly reflecting the natural variations in procollagen and
MMP regulation. Hence, LED therapy did not seem to affect
the cycle per se but seemed to modulate the HRS intrinsic
ability to do so.
The HRS model used in this study emulates skin as a
complex tissue composed of two different compartments: the
epidermis made up mostly of keratinocytes and the under-
lying dermal matrix with fibroblasts as its major cellular
Pre Post
LED
Control
Figure 4. Improvements in skin appearance in aged/photoaged participants
with LED treatment. Digital photograph illustrates periorbital areas at
pre-treatment (a) and posttreatment (c) for the LED-treated side, and at
pre-treatment (b) and posttreatment (d) for the non-treated control area.
All photographs are for S2 aged 38 years.
Table 2. Observers’ assessment of improvement in the severity of wrinkles
Degree of improvement Percentage of subjects X1 point
LED-treated Untreated P-value LED-treated (%) Untreated (%)
Observer 1 1.35±0.11 0.25±0.07 o0.0001 90 25
Observer 2 0.90±0.07 0.70±0.10 NS 85 63
Observer 3 1.03±0.09 0.50±0.09 0.001 85 48
Values are mean±SEM; NS: non-statistically significant.
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components. The limitations of this model reside in the fact
that it does not contain melanocytes, Merkel cells and
Langerhans cells of the epidermis, skin appendages (hair and
glands), vascularization and innervation of the dermis, as
well as its hypodermis counterpart. More complex models
are currently under development. For example, a trilayered
skin substitute consisting of an epidermis, dermis, and an
adipocyte-containing hypodermis has recently been pro-
duced (Trottier et al., 2008). Future experiments with more
complex HRS models should allow extended investigations
into LED-related mechanisms.
Profilometry quantification confirmed a clinical improve-
ment pertaining to skin surface characteristics after 1 month
of LED treatment. Over 90% of participants showed a
reduction in rhytid depth and surface roughness measured
quantitatively by Rz and Ra PRIMOS profilometry after 12
LED treatments. Clinical improvement in wrinkles was
observed in 87% of participants, although one observer
reported no significant differentiation in wrinkling scores
between the treated and untreated sides. Some degree of
improvement was indeed noted on the untreated side in
the qualitative assessments. Although photographs were
randomly presented and the observers were blinded to the
details of the experiment, the fact that the LED-treated side
of the face was the right side in all participants may have
unblinded the study and biased observers. Given that an
improvement on the untreated side was also observed in the
quantitative assessments, however, suggests that the improve-
ment was genuine. The observed improvement on the
untreated side could be due, at least in part, to the fact that
participants were instructed on posttreatment skin care and
closely monitored by the clinical team, which might have
motivated them to take better care of their skin during the trial
period. There is also the possibility that, as the untreated side
was not covered during treatment on the controlateral side, it
benefited from a spill over- or a systemic effect of treatment.
Future studies with split-face designs should randomize
treatment allocation with the untreated side covered.
LED therapy seemed to be well tolerated, with no adverse
events or downtime reported, likely because of the absence
of thermal injury to the skin during treatment. From a clinical
perspective, the nonthermal characteristics of LED treatment
may yield a significant advantage over other treatment
methods, given that effective improvements in the appear-
ance of aged skin can be achieved without thermal damage
induced to skin with associated adverse effects. Additional
studies are, however, needed to evaluate if the clinical
improvements observed in this study are maintained over
time, as follow-up assessments were carried out over a
relatively short period of follow-up time (4 weeks). Our
results are in line with previous accounts of the effectiveness
of LED therapy in photorejuvenation with other light sources
in which effects were observed for up to 6 months follow-up
time points (Weiss et al., 2004, 2005; Bhat et al., 2005;
Russell et al., 2005; Goldberg et al., 2006; Baez and Reilly,
2007; Lee et al., 2007).
The induction of collagen synthesis by nonablative
rejuvenation procedures has been shown to occur largely in
the papillary and upper reticular dermis, forming the so-
called Grenz zone (Hardaway et al., 2002; Nelson et al.,
2002). Our results provide support for previous research
showing that light in the red spectrum, such as 660 nm,
allows for light penetration and absorption in the dermis and
through the entire papillary layer, enabling the stimulation
of collagen production (Simpson et al., 1998). The cascade
of events leading to collagen production is thought to
be initiated by the antenna molecule mitochondrial cyto-
chrome c oxidase (Karu and Kolyakov, 2005; Hamblin and
Demidova, 2006; Karu et al., 2005a, b). Absorbed light
converted to chemical kinetic energy would cause changes in
membrane permeability, improve signaling between mito-
chondria, nucleus and cytosol, lead to nitric oxide formation,
and increase oxidative metabolism to produce more ATP
(Karu, 1989; Morimoto et al., 1994; Yu et al., 1997; Zhang
et al., 2003), ultimately leading to the normalization of
cell activity, including increased collagen production and
MMP regulation.
To our knowledge, these are previously unreported data
on the regulation of skin collagen metabolism in vitro with
clinical correlates using a sequentially pulsed 660 nm LED
source. The HRS used in this study proved to be a good
preclinical model to test the effects of such light treatments on
human skin over a month, and permitted to investigate the
mechanism(s) responsible for the positive changes observed
in the skin of LED-treated humans. The characteristics of the
participants included in this trial, the study setting, the
treatment regimens tested, and the outcomes assessed are
similar to those encountered in day-to-day dermatology
practice. The results from this study thus support 660 nm
LED as a collagen-enhancement strategy that can be used
safely in a clinical setting. Yet, additional studies are needed
to evaluate whether 660 nm LED effects are maintained over
time. Further studies are also warranted to ascertain the
cellular processes involved.
IN VITRO STUDY MATERIALS AND METHODS
Cell culture media
Keratinocytes were grown in a complete DME-HAM medium: a
combination of Dulbecco–Vogt modification of Eagle’s medium
(DME) with Ham’s F12 in a 3:1 proportion (Invitrogen, Burlington,
Canada), supplemented with 5% Fetal Clone II serum (FCSII) (HyClone,
Logan, UT), 10ngml epidermal growth factor (Austral Biologicals, San
Ramon, CA), 24.3mgml adenin (Sigma-Aldrich, Oakville, Canada),
5mgml insulin (Sigma-Aldrich), 5mgml transferrin (Roche Diagnostics,
Laval, Canada), 2 109 M 3,30 50 triiodo-L-thyronin (Sigma-Aldrich),
0.4mgml hydrocortisone (Calbiochem, La Jolla, CA), and antibiotics
100 IUml penicillin G (Sigma-Aldrich) and 25mgml gentamicin
(Schering, Pointe-Claire, Canada). Fibroblasts were cultured in DME
containing 10% fetal calf serum (HyClone) and antibiotics.
Cell isolation and culture
Skin specimens were collected from healthy women aged 38
(HRS38), 42 (HRS42), and 64 (HRS64) years, during reductive breast
surgery (HRS38 and HRS42) or face-lift (HRS64). Procedures for cell
isolation were initiated within 3 hours after surgery according to a
previously published method (Germain et al., 2001; Auger et al.,
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2002). Skin specimens were washed five times with a phosphate-
buffered saline supplemented with antibiotics. Specimens were then
cut into 3mm wide strips and kept overnight at 4 1C in Hepes buffer
containing 500mgml thermolysin. The epidermis was mechanically
separated from the dermis with forceps; keratinocytes were
dissociated from the epidermis through incubation of the epidermal
fragments under agitation at 371C for 30minutes, with 0.05%
trypsin-0.1% EDTA in PBS. After trypsin inactivation (addition of
culture medium containing 10% serum and centrifugation), keratino-
cytes were expanded in the presence of irradiated 3T3 fibroblasts
in T75 flasks (BD Biosciences, Mississauga, Canada) and subse-
quently frozen until further use. Fibroblasts were dissociated from
the remaining dermis fragments after incubation in a colla-
genase H solution at 371C under agitation. After centrifugation, the
fibroblasts were also plated in T75 flasks for expansion and
subsequently frozen until further use.
Production of tissue-engineered HRS
The cells isolated from the healthy women aged 38, 42, and 64 years
were used to reconstruct HRS38, HRS42, and HRS64, respectively.
HRS were produced as previously described (Michel et al. 1999).
Briefly, fibroblasts (F38, F42, or F64) were cultivated in a fibroblast
culture medium containing 50 mgml sodium ascorbate (Sigma-
Aldrich) for 4 weeks until cell sheets were formed. After peeling
the fibroblast sheets from the bottom of the dishes, two sheets were
superimposed, for a total of two sheets per HRS, and cultured for 1
week. After dermal equivalent maturation, keratinocytes (250,000
cells per cm2, between cellular passages 2 and 3) were seeded on
reconstructed stroma and cultured for 7 days in a keratinocyte
complete medium (containing 50 mgml sodium ascorbate) under
submerged conditions. The HRS were then brought to the air–liquid
interface and cultivated in complete DME-HAM with 5% serum and
50 mgml sodium ascorbate, without EGF, for an additional 4 weeks.
The culture medium was changed three times per week. Each
experimental condition was tested in triplicate on the three HRS
tested (HRS38, HRS42, and HRS64). All plastic ware for tissue
culture was procured from BD Biosciences.
LED and sham light treatments
Samples of the HRS replicates were exposed to the LED or sham light
source under a laminar flow hood. HRS were treated 11 times (T1 to
T11) over a 1-month period, treatments were performed three times
a week for 4 consecutive weeks, with only two treatments performed
in the fourth week. Cultures were then incubated at 371C (8% CO2).
Supernatants were collected before each treatment and after the last
treatment, and stored at 201C until assessed for type I procollagen
and MMP-1.
The LED technique involved the application of a 660-nm
wavelength delivered in a sequential pulsing mode at a power
density of 50mWcm for a total fluence of 4 J cm, for a duration of
160 seconds (2m40 s) (LumiPhase-R, OPUSMED Inc. Montreal,
Canada). The pulsing patterns and time on and time off sequences
were as follows: Pulse width (time on) 500 msec, pulse interval (time
off) 150 msec, four pulses per pulse train, and a pulse train interval of
1,550msec. The non-treated HRS samples were exposed to a sham
light for 160 seconds with a total fluence of 0 J cm.
During this study, a lot of care was taken to maintain a working
distance of 2.5 cm (±1mm) away from the target surface during LED
therapy, as power density/light intensity—a key variable for optimal
photoinduction—is greatly influenced by the distance between the
light source and the surface of the skin (Hart and Cameron, 2005).
Measurements of the intensity (mW) of the LED light source emitting
at 660 nm (110mA CW) were taken with a ph100-si (Gentec-eo,
Quebec, Canada) at every centimeter, up to a 10-cm distance away
from the light source. This was important to ensure that the proper
amount of photons was delivered to reach the cellular activation
(induction) threshold in the skin.
Type I collagen and MMP-1 determination
Human type I collagen was measured in cell culture supernatants of
the selected time period with the Protype I collagen C-peptide
enzyme immunoassay kit purchased from Takara Mirus Bio
(Madison, WI), according to the manufacturer’s instructions. MMP-1
levels were also measured using MMP-1 biotrak activity assay systems
according to the manufacturer’s instructions (Amersham Biosciences,
Baie D’Urfe, Canada).
Data analysis
As an indication of effect size to measure the direction and
magnitude of the treatment effect for each time point, Cohen’s d
was used. Cohen’s d was computed as follows: d is the difference in
group means divided by the pooled s.d. A standardized effect size
of 0.2 is considered small, 0.5 is considered medium, and 0.8 is
considered large (Cohen, 1988).
Histological analysis
After the last treatment, biopsies of untreated and LED-treated
reconstructed skin were fixed for at least 24 hours in a Bouin solution
(ACP, St Leonard, Canada) and embedded in paraffin.
Five-mm-thick cross-sections were stained with Masson’s trichrome.
Photographs were taken at the  40 objective with a digital
camera (CoolSnap RS Photometrics, Roper Scientific, Munich,
Germany).
Indirect immunofluorescence microscopy
At the end of the treatment series, samples of the untreated and
LED-treated reconstructed skin were embedded and frozen in
OCT compound (Somagen, Edmonton, Canada). Four-mm-thick
cross-sections were fixed in cold acetone and further incubated with
mouse monoclonal anti-human type I collagen antibody (Chemicon,
Temecula, CA). The secondary antibodies (Chemicon) used were
rhodamine-conjugated goat anti-mouse IgG-IgM and goat anti-rabbit
IgG. Nuclei were stained blue with Hoechst 33258 (Sigma-Aldrich).
IN VIVO STUDY MATERIALS AND METHODS
Participant selection
Forty healthy patients with aged/photoaged skin (37 women and 3
men) with a mean age of 44.9 (33–62) years were recruited from the
Dr. Daniel Barolet Clinic in Montreal, Canada from September 2002
to December 2002 and tested between January 03 and April 03.
Inclusion criteria included patients with skin type I to III according to
the FCS (Fitzpatrick, 1988). At study entry, 15% of patients were skin
type I, 45% were skin type II, and 40% were skin type III. A total of
48% were deemed to present with mild, 38% with moderate, and
10% with a severe degree of wrinkles, according to the FSC for
degree of wrinkling (rhytids).
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Exclusion criteria comprised patients taking cortisone (predni-
sone), anticoagulant therapy, or any drug known to increase
photosensitivity. In addition, during the 12 months preceding the
study, patients were required not to have used isotretinoin
(Accutane) or applied topical steroids to the site to be treated.
Moreover, a previous laser or topical medication at the to-be-treated
site was not permitted. Patients gave written, informed consent
to participate in this trial in compliance with the US Code of
Federal Regulations dealing with the conduct of clinical studies
(21CFR including parts 50 and 56 with regard to informed consent
and IRB regulations). The study was conducted according to
Good Clinical Practice Guidelines and the principles of the
Declaration of Helsinki, and was approved by the Institutional
Review Board Services (Div. 1373737 Toronto, Canada). The
trial was registered with ClinicalTrials.Gov (ClinicalTrials.gov
Identifier: NCT00818246). The study flow chart is presented in
Figure 5.
Study design
This was a split-face single-blinded study to assess the efficacy of
LED treatment on overall skin appearance (rhytids depth and
texture—surface roughness) of the aged/photoaged periorbital area.
This study design allowed for within-participant assessments of
clinical effects. Assignment: The right periorbital area was desig-
nated to be the experimental side, and the left periorbital was used as
control (sham light). Blinding: The observers who performed the
clinical qualitative assessments on the basis of digital photographs
were blinded to the treatment regimen (LED-treated or untreated/
control side) and to the timing of the photographs (pre- or
posttreatment).
Study procedure
Participants were treated three times weekly for 4 consecutive weeks
(12 treatments) with the 660 nm-pulsed LED device on the
experimental periorbital area. LED treatments were administered
using the same parameters as those for the in vitro study (see In vitro
Study Materials and Methods). To maximize LED photoinduction, a
topical moisturizer without active ingredients was applied daily, as
dry skin is known to enhance skin surface reflectivity (Friedman
et al., 2002). To support photobiochemical reactions in the triggering
of gene-expression-enhanced collagen metabolism during LED
exposure, skin temperature should be kept normal, that is,
physiological (Halper et al., 2005). Therefore, monitoring papillary
dermis temperature with a needle probe (type-T thermocouple from
Omega, Montreal, Canada) during LED treatment was carried out.
The control side was exposed to a sham light for 160 seconds with a
total fluence of 0 J cm. No cooling method was used after exposure.
To avoid hiding periorbital skin, a well-circumscribed external
eyelid protector (Oculoplastik, Montreal, Canada) was worn to
protect the retina from direct illumination. Before returning home,
participants were instructed on posttreatment skin care, which
included applying a plain moisturizer on both sides of the face, sun
avoidance, and the use of a sunscreen (SPF 30).
Primary outcome measures
A topographical quantitative assessment was carried out for each
study participant using PRIMOS 3D surface topography (GFM,
Teltow, Germany) profilometry performing phase shift rapid
in vivo measurements of skin from the experimental and control
periorbital areas before treatment and 4 weeks after treatment. A
PRIMOS readings (PRIMOS 4 Software, GFM, Teltow, Germany)
star analysis was carried out, from a phase shift photograph, a
1.5 cm-diameter circular portion of the skin on the lateral cantus
area was cut into 12 equal segments, allowing depth calculation
of fine surface lines (peak and valley analysis) in that area and
quantification of skin surface roughness. The Ra value was
calculated from general surface roughness characteristics, pore
size and skin texture. The Rz value obtained for each participant was
Enrollment
Allocation
Follow-up Lost to Follow-up: n=0Discontinued: n=0
Analyzed
Qualitative assessment: n=40
Excluded from analysis: n=0
Analysis
Analyzed
Quantitative assessment: n=35
Excluded from analysis: n=5
Given reason: Impossibility to
match before and after
PRIMOS pictures
Meeting criteria: n=40
Allocated to intervention: n=40
Spilt-face study
Right side: LED treatment
Left side: Sham light treatment
Figure 5. Clinical study flow chart.
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estimated from average peak and valley measurement data to
quantify rhytid depth and severity. Pre- and posttreatment surface
topography measurements were taken to precisely quantify clinical
improvements.
Secondary outcome measures
A clinical qualitative assessment was carried out by three blinded
medical observers through the evaluation of digital photographs
(Canon Dual Flash E2, Mississauga, Canada) of the experimental and
control periorbital areas taken pre-treatment and 4 weeks posttreat-
ment for each participant. Each photograph was taken maintaining
identical ambient lighting, pose, and camera angles. To avoid bias in
clinical appraisal, sets of photographs for the treated and untreated
sides of the face were randomly presented to the observers who were
blinded to the details of the experiment. The photographs were
analyzed for clinical improvement using the FCS subtype scale for
degree of wrinkling (rhytids). Their assessment was rated on a five-
point scale and scored as follows: 0¼ none, 1¼mild, 2¼moderate,
3¼ good, 4¼ excellent. Adverse effects were monitored over the
entire course of the study.
Data analysis
Sample sizes and power calculations were generated according to
the primary outcome measures of the study. To have a 98% chance
of detecting as significant (at the two-sided 5% level) a 10%
difference between the treated and untreated/control sides in the Ra
and Rz posttreatment improvement, with an assumed s.d. of 10, 33
participants were required. To account for an 80% per protocol
completion rate, the planned number of patients to be enrolled was 40.
The primary outcome variables were the percent improvement
posttreatment for the Ra and Rz values measured 4 weeks
posttreatment. The primary outcome analysis was conducted on
results from 35 participants. The data from five participants were
removed from the quantitative assessment analysis because of the
fact that it was not possible to match the before and after PRIMOS
data digital color-coded photographs. The secondary clinical
outcome variable was the medical observers’ combined gain in
the FCS score for degree of wrinkling 4 weeks after treatment.
Secondary outcome analysis was conducted on the results
of the total sample of participants (n¼ 40). For the primary and
secondary outcome variables, an analysis of covariance was used to
assess statistical differences between the LED-treated and untreated
sides, taking into account age as the covariate. Main effects and two-
way interactions were incorporated into the statistical model.
Tukey’s HSD test was used to assess pairwise comparisons.
Cronbach’s a was calculated to assess internal consistency between
the observers’ assessments. P-values were considered significant
at Pp0.05.
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